menu
    • menu

    Find Nesuparib manufacturers, exporters & distributors on PharmaCompass

    NEW Prospects: 1
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    DEVELOPMENTS

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    0

    API Suppliers

    0

    USDMF

    0

    CEP/COS

    0

    JDMF

    0

    EU WC

    0

    KDMF

    0

    NDC API

    0

    VMF

    0

    Listed Suppliers

    0INTERMEDIATES

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    0

    USP

    0

    JP

    0

    Others

    FINISHED DOSAGE FORMULATIONS

    0

    FDF Dossiers

    0

    FDA Orange Book

    0

    Europe

    0

    Canada

    0

    Australia

    0

    South Africa

    0

    Listed Dossiers

    1PROSPECTS

    5DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    0RELATED EXCIPIENT COMPANIES

    0EXCIPIENTS BY APPLICATIONS

    PATENTS & EXCLUSIVITIES

    0

    US Patents

    0

    US Exclusivities

    0

    Health Canada Patents

    API/FDF Prices: Book a Demo

    API REF. PRICE (USD/KG)

    $
    $ 0

    GLOBAL SALES INFORMATION

    US Medicaid

    NA

    Annual Reports

    NA

    Regulatory FDF Prices

    NA

    MARKET PLACE

    0

    API

    0

    FDF

    DIGITAL CONTENT

    0

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    0

    News #PharmaBuzz

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 2055357-64-5, Jpi-547, Jpi547, U6n7333gdw, Nesuparib [inn], Jpi 547
    Molecular Formula
    C23H24N6O
    Molecular Weight
    400.5  g/mol
    InChI Key
    GRPXLKXGJAGYSD-UHFFFAOYSA-N
    FDA UNII
    U6N7333GDW
    Nesuparib
    NESUPARIB is a small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications.
    1 2D Structure

    Nesuparib

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    6-[4-[(5-oxo-2,3,4,6-tetrahydro-1H-benzo[h][1,6]naphthyridin-8-yl)methyl]piperazin-1-yl]pyridine-3-carbonitrile
    2.1.2 InChI
    InChI=1S/C23H24N6O/c24-13-17-4-6-21(26-14-17)29-10-8-28(9-11-29)15-16-3-5-18-20(12-16)27-23(30)19-2-1-7-25-22(18)19/h3-6,12,14,25H,1-2,7-11,15H2,(H,27,30)
    2.1.3 InChI Key
    GRPXLKXGJAGYSD-UHFFFAOYSA-N
    2.2 Other Identifiers
    2.2.1 UNII
    U6N7333GDW
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. 2055357-64-5

    2. Jpi-547

    3. Jpi547

    4. U6n7333gdw

    5. Nesuparib [inn]

    6. Jpi 547

    7. 6-(4-((5-oxo-1,2,3,4,5,6-hexahydrobenzo(h)(1,6)naphthyridin-8-yl)methyl)piperazin-1-yl)nicotinonitrile

    8. 6-(4-((5-oxo-1,2,3,4,5,6-hexahydrobenzo[h][1,6]naphthyridin-8-yl)methyl)piperazin-1-yl)nicotinonitrile

    9. Refchem:165540

    10. Jpi-547 [who-dd]

    11. Parp/tnk Inhibitor Jpi-547

    12. Nov 1402

    13. Parp1/2/tnk1/2 Inhibitor Jpi-547

    14. Nov140201

    15. Unii-u6n7333gdw

    16. Orb1688106

    17. Chembl5095245

    18. Jpi 547 [who-dd]

    19. Schembl18314125

    20. Schembl29411324

    21. Schembl30093972

    22. Glxc-26951

    23. Ex-a6172

    24. Da-76112

    25. Ms-26808

    26. Hy-145584

    27. Cs-0376456

    28. H39853

    29. 6-[4-[(1,2,3,4,5,6-hexahydro-5-oxobenzo[h]-1,6-naphthyridin-8-yl)methyl]-1-piperazinyl]-3-pyridinecarbonitrile

    2.4 Create Date
    2017-02-18
    3 Chemical and Physical Properties
    Molecular Weight 400.5 g/mol
    Molecular Formula C23H24N6O
    XLogP31.8
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count6
    Rotatable Bond Count3
    Exact Mass Da
    Monoisotopic Mass Da
    Topological Polar Surface Area84.3
    Heavy Atom Count30
    Formal Charge0
    Complexity733
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search